James (Jim) Kellerman is a seasoned intellectual property attorney with extensive leadership experience in the pharmaceutical and biotechnology industries. Over the course of his career, Jim has advised senior and executive leadership on complex legal and IP matters, helping organizations navigate strategic transactions, product development, and commercialization. His work spans acquisitions, in-licensing, and collaborative agreements, where he has played a key role in aligning legal strategy with business objectives.

Jim has led global intellectual property teams responsible for protecting and advancing high-value portfolios across a wide range of technologies. He brings deep experience in IP strategy, including portfolio development, enforcement, defense, and freedom-to-practice analysis. In addition, he has overseen global patent litigation matters and guided organizations through risk mitigation and due diligence processes throughout the product lifecycle—from research through commercialization.

Jim earned his Juris Doctor from Franklin Pierce Law Center, and holds a Bachelor of Science from the University of Cincinnati College of Pharmacy.